RTA Laboratuvarlari Biyolojik Market Cap ($22.17 Million)
Market Cap & Net Worth: RTA Laboratuvarlari Biyolojik (RTALB)
RTA Laboratuvarlari Biyolojik market cap. RTA Laboratuvarlari Biyolojik (IS:RTALB) has a market capitalization of $22.17 Million (TL990.00 Million) as of November 8, 2026. Listed on the IS stock exchange, this Turkey-based company holds position #24593 globally and #387 in its home market, demonstrating a 2.06% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying RTA Laboratuvarlari Biyolojik's stock price TL1.98 by its total outstanding shares 500000000 (500.00 Million). Also see RTA Laboratuvarlari Biyolojik operating cash flow efficiency for how efficiently the company converts equity into cash flow.
RTA Laboratuvarlari Biyolojik Market Cap History (2015–2026)
RTA Laboratuvarlari Biyolojik market cap history from 2015 to 2026. Data shows growth from $12.91 Million to $22.17 Million (4.65% CAGR). Check RTA Laboratuvarlari Biyolojik (RTALB) share price today for real-time trading data and today's change.
RTA Laboratuvarlari Biyolojik Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how RTA Laboratuvarlari Biyolojik's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore RTALB shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.02x
RTA Laboratuvarlari Biyolojik's market cap is 1.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.11x
RTA Laboratuvarlari Biyolojik's market cap is 3.11 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $12.91 Million | $33.68 Million | $7.48 Million | 0.38x | 1.73x |
| 2016 | $9.00 Million | $31.81 Million | $4.09 Million | 0.28x | 2.20x |
| 2017 | $12.39 Million | $38.45 Million | $4.16 Million | 0.32x | 2.98x |
| 2018 | $7.81 Million | $20.47 Million | $601.21K | 0.38x | 12.99x |
| 2019 | $11.16 Million | $16.77 Million | $4.42 Million | 0.67x | 2.52x |
| 2020 | $145.71 Million | $230.44 Million | $60.93 Million | 0.63x | 2.39x |
| 2021 | $106.54 Million | $384.34 Million | $114.47 Million | 0.28x | 0.93x |
| 2022 | $145.47 Million | $86.03 Million | $281.12 Million | 1.69x | 0.52x |
| 2023 | $160.59 Million | $138.51 Million | -$103.16 Million | 1.16x | N/A |
| 2024 | $162.49 Million | $158.59 Million | $52.23 Million | 1.02x | 3.11x |
Competitor Companies of RTALB by Market Capitalization
Companies near RTA Laboratuvarlari Biyolojik in the global market cap rankings as of November 8, 2026. Also see how large is RTA Laboratuvarlari Biyolojik's balance sheet for a full breakdown of the balance sheet.
Key companies related to RTA Laboratuvarlari Biyolojik by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #177 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #363 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #403 globally with a market cap of $69.36 Billion USD ( AU$98.02 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #177 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $547.09 |
| #363 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $904.35 |
| #403 | CSL Ltd | AU:CSL | $69.36 Billion | AU$202.04 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $254.19 |
Market Capitalization of RTA Laboratuvarlari Biyolojik (2015–2026)
Market capitalization of RTA Laboratuvarlari Biyolojik from 2015 to today. Between 2015 and today, RTA Laboratuvarlari Biyolojik's market cap moved from $12.91 Million to $ 22.17 Million, with a yearly change of 4.65%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | TL22.17 Million | -42.27% |
| 2025 | TL38.41 Million | -76.36% |
| 2024 | TL162.49 Million | +1.19% |
| 2023 | TL160.59 Million | +10.39% |
| 2022 | TL145.47 Million | +36.54% |
| 2021 | TL106.54 Million | -26.88% |
| 2020 | TL145.71 Million | +1205.19% |
| 2019 | TL11.16 Million | +42.90% |
| 2018 | TL7.81 Million | -36.95% |
| 2017 | TL12.39 Million | +37.66% |
| 2016 | TL9.00 Million | -30.26% |
| 2015 | TL12.91 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of RTA Laboratuvarlari Biyolojik was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $22.17 Million USD |
| MoneyControl | $22.17 Million USD |
| MarketWatch | $22.17 Million USD |
| marketcap.company | $22.17 Million USD |
| Reuters | $22.17 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About RTA Laboratuvarlari Biyolojik
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. engages in the research, development, and production of microbiology and molecular biology products in Turkey. It offers microbiology products, including petri dish, tube and bottle, chromogenic media, blood culture bottle, tuberculosis diagnostic, rapid test, microbiological stain, hygislide, surcheck media, membrane, paint… Read more